TY - JOUR
T1 - 10 practical priorities to prevent and manage serious allergic reactions
T2 - GA2LEN ANACare and EFA Anaphylaxis Manifesto
AU - GALEN ANACare Centres and EFA
AU - Muraro, Antonella
AU - de Silva, Debra
AU - Podesta, Marcia
AU - Anagnostou, Aikaterini
AU - Cardona, Victoria
AU - Halken, Susanne
AU - Smith, Pete
AU - Tanno, Luciana Kase
AU - Turner, Paul
AU - Worm, Margitta
AU - Alvaro-Lozano, Montserrat
AU - Arasi, Stefania
AU - Asarnoj, Anna
AU - Barni, Simona
AU - Beyer, Kirsten
AU - Bilaver, Lucy A.
AU - Bird, Andrew
AU - Bonaguro, Roberta
AU - Brough, Helen A.
AU - Chinthrajah, R. Sharon
AU - Cook, Emma E.
AU - Demoulin, Céline
AU - Deschildre, Antoine
AU - Dribin, Timothy E.
AU - Ebisawa, Motohiro
AU - Fernandez-Rivas, Montserrat
AU - Fiocchi, Alessandro
AU - Fleischer, David M.
AU - Garrow, Eleanor
AU - Gerdts, Jennifer
AU - Giovannini, Mattia
AU - Järvinen, Kirsi M.
AU - Kelly, Mary
AU - Knol, Edward F.
AU - Lack, Gideon
AU - Lazzarotto, Francesca
AU - Le, Thuy My
AU - Leonard, Stephanie
AU - Lieberman, Jay
AU - Makris, Michael
AU - Mandelbaum, Lianne
AU - Marchisotto, Mary Jane
AU - Marino, Gustavo Andres
AU - Mori, Francesca
AU - Nilsson, Caroline
AU - Nowak-Wegrzyn, Anna
AU - Odemyr, Mikaela
AU - Oude Elberink, H. N.G.
AU - Palosuo, Kati
AU - Patel, Nandinee
N1 - Publisher Copyright:
© 2024 The Author(s). Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.
PY - 2024/12
Y1 - 2024/12
N2 - This Anaphylaxis Manifesto calls on communities to prioritise 10 practical actions to improve the lives of people at risk of serious allergic reactions. The Global Allergy and Asthma European Network and the European Federation of Allergy and Airways Diseases Patients' Associations (EFA) compiled patient-centric priorities. We used qualitative consensus methods, research evidence and feedback from over 200 patient groups, stakeholder organisations and healthcare professionals. We encourage healthcare, education and food organisations to collaborate with people at risk of serious allergic reactions to tackle safety, anxiety and financial burdens for individuals and societies. Key priorities for prevention include awareness-raising campaigns for the public and professionals, school and workplace initiatives and mandatory precautionary allergen labels on food. Priorities for improving immediate and long-term management include educating healthcare professionals, patients and schools about when and how to use adrenaline, funding two approved adrenaline devices for everyone at risk, and facilitating access to allergy specialists. Integrated care pathways should include clinical and non-clinical management options such as individualised risk assessment and quality of life assessment, self-management plans, dietetic and psychosocial support and peer support. Organisations around the world are committing to work together towards these priorities.
AB - This Anaphylaxis Manifesto calls on communities to prioritise 10 practical actions to improve the lives of people at risk of serious allergic reactions. The Global Allergy and Asthma European Network and the European Federation of Allergy and Airways Diseases Patients' Associations (EFA) compiled patient-centric priorities. We used qualitative consensus methods, research evidence and feedback from over 200 patient groups, stakeholder organisations and healthcare professionals. We encourage healthcare, education and food organisations to collaborate with people at risk of serious allergic reactions to tackle safety, anxiety and financial burdens for individuals and societies. Key priorities for prevention include awareness-raising campaigns for the public and professionals, school and workplace initiatives and mandatory precautionary allergen labels on food. Priorities for improving immediate and long-term management include educating healthcare professionals, patients and schools about when and how to use adrenaline, funding two approved adrenaline devices for everyone at risk, and facilitating access to allergy specialists. Integrated care pathways should include clinical and non-clinical management options such as individualised risk assessment and quality of life assessment, self-management plans, dietetic and psychosocial support and peer support. Organisations around the world are committing to work together towards these priorities.
KW - adrenaline
KW - allergy
KW - anaphylaxis
KW - hypersensitivity
UR - http://www.scopus.com/inward/record.url?scp=85210757751&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85210757751&partnerID=8YFLogxK
U2 - 10.1002/clt2.70009
DO - 10.1002/clt2.70009
M3 - Review article
C2 - 39614094
AN - SCOPUS:85210757751
SN - 2045-7022
VL - 14
JO - Clinical and Translational Allergy
JF - Clinical and Translational Allergy
IS - 12
M1 - e70009
ER -